OBJECTIVE: A previous pilot trial evaluating computer-based training for cognitive-behavioral therapy (CBT4CBT) in 77 heterogeneous substance users (alcohol, marijuana, cocaine, and opioids) demonstrated preliminary support for its efficacy in the context of a community-based outpatient clinic. The authors conducted a more definitive trial in a larger, more homogeneous sample. METHOD: In this randomized clinical trial, 101 cocaine-dependent individuals maintained on methadone were randomly assigned to standard methadone maintenance or methadone maintenance with weekly access to CBT4CBT, with seven modules delivered within an 8-week trial. RESULTS:Treatment retention and data availability were high and comparable across the treatment conditions. Participants assigned to the CBT4CBT condition were significantly more likely to attain 3 or more consecutive weeks of abstinence from cocaine (36% compared with 17%; p<0.05, odds ratio=0.36). The group assigned to CBT4CBT also had better outcomes on most dimensions, including urine specimens negative for all drugs, but these reached statistical significance only for individuals completing the 8-week trial (N=69). Follow-up data collected 6 months after treatment termination were available for 93% of the randomized sample; these data indicate continued improvement for those assigned to the CBT4CBT group, replicating previous findings regarding its durability. CONCLUSIONS: This trial replicates earlier findings indicating that CBT4CBT is an effective adjunct to addiction treatment with durable effects. CBT4CBT is an easily disseminable strategy for broadening the availability of CBT, even in challenging populations such as cocaine-dependent individuals enrolled in methadone maintenance programs.
RCT Entities:
OBJECTIVE: A previous pilot trial evaluating computer-based training for cognitive-behavioral therapy (CBT4CBT) in 77 heterogeneous substance users (alcohol, marijuana, cocaine, and opioids) demonstrated preliminary support for its efficacy in the context of a community-based outpatient clinic. The authors conducted a more definitive trial in a larger, more homogeneous sample. METHOD: In this randomized clinical trial, 101 cocaine-dependent individuals maintained on methadone were randomly assigned to standard methadone maintenance or methadone maintenance with weekly access to CBT4CBT, with seven modules delivered within an 8-week trial. RESULTS: Treatment retention and data availability were high and comparable across the treatment conditions. Participants assigned to the CBT4CBT condition were significantly more likely to attain 3 or more consecutive weeks of abstinence from cocaine (36% compared with 17%; p<0.05, odds ratio=0.36). The group assigned to CBT4CBT also had better outcomes on most dimensions, including urine specimens negative for all drugs, but these reached statistical significance only for individuals completing the 8-week trial (N=69). Follow-up data collected 6 months after treatment termination were available for 93% of the randomized sample; these data indicate continued improvement for those assigned to the CBT4CBT group, replicating previous findings regarding its durability. CONCLUSIONS: This trial replicates earlier findings indicating that CBT4CBT is an effective adjunct to addiction treatment with durable effects. CBT4CBT is an easily disseminable strategy for broadening the availability of CBT, even in challenging populations such as cocaine-dependent individuals enrolled in methadone maintenance programs.
Authors: Kathleen M Carroll; Samuel A Ball; Steve Martino; Charla Nich; Theresa A Babuscio; Kathryn F Nuro; Melissa A Gordon; Galina A Portnoy; Bruce J Rounsaville Journal: Am J Psychiatry Date: 2008-05-01 Impact factor: 18.112
Authors: Kathleen M Carroll; Samuel A Ball; Steve Martino; Charla Nich; Theresa A Babuscio; Bruce J Rounsaville Journal: Drug Alcohol Depend Date: 2008-11-28 Impact factor: 4.492
Authors: Nancy M Petry; John M Roll; Bruce J Rounsaville; Samuel A Ball; Maxine Stitzer; Jessica M Peirce; Jack Blaine; Kimberly C Kirby; Dennis McCarty; Kathleen M Carroll Journal: J Consult Clin Psychol Date: 2008-12
Authors: Sarah W Yip; Elise E DeVito; Hedy Kober; Patrick D Worhunsky; Kathleen M Carroll; Marc N Potenza Journal: Drug Alcohol Depend Date: 2016-07-16 Impact factor: 4.492
Authors: Brent A Moore; Frank D Buono; Daniel P Lloyd; Destiny M B Printz; David A Fiellin; Declan T Barry Journal: J Subst Abuse Treat Date: 2018-11-24
Authors: Brian D Kiluk; Charla Nich; Matthew B Buck; Kathleen A Devore; Tami L Frankforter; Donna M LaPaglia; Srinivas B Muvvala; Kathleen M Carroll Journal: Am J Psychiatry Date: 2018-05-24 Impact factor: 18.112
Authors: Kelly Serafini; Bo Malin-Mayor; Charla Nich; Karen Hunkele; Kathleen M Carroll Journal: Am J Drug Alcohol Abuse Date: 2016-02-23 Impact factor: 3.829
Authors: André Q C Miguel; Ayana Jordan; Brian D Kiluk; Charla Nich; Theresa A Babuscio; Jair J Mari; Kathleen M Carroll Journal: J Subst Abuse Treat Date: 2019-08-28
Authors: André Q C Miguel; Brian D Kiluk; Corey R Roos; Theresa A Babuscio; Charla Nich; Jair J Mari; Kathleen M Carroll Journal: J Subst Abuse Treat Date: 2019-09-05